Product Offerings
Product Categories:
Feed Additives and Ingredients, Consulting and Professional Services
Products:
Antimicrobials: CIPROMOX, CORIVET T, DAIVET FORTE, CIPROFARM 20, NORFIN 20, PRO-ENROVET 10, PRO-ENROVET 20, VETMOXIL
Feed Additives and Ingredients, Consulting and Professional Services
Antimicrobials: CIPROMOX, CORIVET T, DAIVET FORTE, CIPROFARM 20, NORFIN 20, PRO-ENROVET 10, PRO-ENROVET 20, VETMOXIL
PHARMAVET CORPORATION S.A.C., headquartered in Lima, Peru, is a dynamic veterinary pharmaceutical company specializing in the manufacturing, import, export, and commercialization of animal health products. With a strong presence across Latin America, the company is recognized for its extensive range of veterinary medicines, commitment to innovation, and contribution to sustainable livestock and poultry production.
The core business of PHARMAVET CORPORATION S.A.C. is the development and distribution of veterinary pharmaceuticals and nutritional supplements for livestock and poultry. The company provides a broad spectrum of therapeutic solutions including antimicrobials, antiparasitics, enzyme activators, antipyretics, hepatoprotectors, and more.
Its vertically integrated operations include formulation, product development, registration, and nationwide as well as international distribution. PHARMAVET also partners with contract manufacturers and international suppliers to broaden its portfolio and ensure product availability in high-demand regions.
PHARMAVET's product lines include:
Antimicrobials:
Vitamins and Nutritional Support:
Antiparasitics and Coccidiostats:
Enzyme Activators & Hepatoprotectors:
Non-Antibiotic Antidiarrheals:
Disinfectants and Pesticides:
Each product is supported with regulatory dossiers, usage protocols, and veterinary guidance.
PHARMAVET’s core specialization lies in its broad-spectrum antimicrobial range, cost-effective formulations, and rapid market responsiveness. Key differentiators include:
Their products are designed for ease of administration, rapid action, and farm-level affordability.
As a privately owned corporation operating within a high-growth sector, PHARMAVET’s financial data is not publicly disclosed. However, market indicators and regional reports suggest:
Revenue growth is driven by expansion of its antimicrobial and vitamin portfolios, alongside increased demand for poultry therapeutics.
According to regional trade data:
Export operations are supported by established regulatory registrations and partnerships with regional logistics providers.
PHARMAVET CORPORATION S.A.C. caters to:
Their customer base includes both industrial and small-scale producers across emerging animal production regions.
PHARMAVET maintains agility and innovation across all functions while scaling its reach through strategic partnerships.
The company ensures regulatory compliance across its operations:
Quality control processes include raw material testing, batch validation, and stability analysis.
“We rely on PHARMAVET’s antimicrobial solutions for quick response in our broiler operations. Their field team provides reliable support and disease insights.”
— Carlos M., Farm Manager, Ecuador
“DAIVET FORTE and VETMOXIL have been key to maintaining productivity in our piggery. Excellent product availability and technical follow-up.”
— Lucía V., Swine Veterinarian, Peru
PHARMAVET CORPORATION S.A.C. continues to grow as a trusted veterinary pharmaceutical partner, delivering science-backed, accessible solutions that support animal health and production efficiency across Latin America.